This Diversified Healthcare Stock Offers Explosive Biotech-Like Growth
Investing early in biotech and pharmaceutical companies can lead to some massive multi-bagger returns. However, these returns almost always come with vast amounts of risk and volatility tied to the pipeline of products.
These risks seem almost unavoidable when looking at stocks with drugs in clinical trials. Yet there is one company that offers the potential to grow alongside these drug-makers, all while providing safety through diversification to the broader industry. This company is Medpace Holdings (NASDAQ: MEDP), a clinical trial specialist whose mission is to "accelerate the global development of safe and effective medical therapeutics."
Image source: Getty Images.
Source Fool.com
